ZRSR2 and myelodysplastic syndrome: ZRSR2 somatic mutations, which occur in approx. 3–7% of MDS [6,7,60] are widely distributed along the entire coding region, and correspond to nonsense or frameshift changes or alteration of splicing donor/acceptor sites, consistent with loss of function.